| Symbol | OGI |
|---|---|
| Name | ORGANIGRAM GLOBAL INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Address | 35 ENGLISH DRIVE, MONCTON, New Brunswick, E1E 3X3, Canada |
| Telephone | +1 506 801-8986 |
| Fax | — |
| — | |
| Website | https://www.organigram.ca |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001620737 |
| Description | Organigram Inc. is a Canadian licensed producer of cannabis products. Organigram focuses on producing exceptional, indoor-grown cannabis for patients and adult recreational consumers, as well as developing global business partnerships. Additional info from NASDAQ: |
Organigram annonce des résultats records pour le troisième trimestre de l’exercice 2026
Read moreOrganigram meldet Rekordergebnisse für das dritte Quartal des Geschäftsjahres 2026
Read moreSamenvatting: Organigram maakt recordresultaten bekend voor het derde kwartaal van boekjaar 2026
Read moreRiassunto: Organigram annuncia risultati da record per il terzo trimestre dell'anno fiscale 2026
Read moreResumen: Organigram da a conocer los resultados récord del tercer trimestre del ejercicio fiscal 2026
Read moreOrganigram to Report Third Quarter Fiscal 2026 Results on August 11, 2026
Read moreOrganigram Provides Business Update Highlighting Initial Sanity Performance and Canadian Market Share
Read moreOrganigram to Report Second Quarter Fiscal 2026 Results on May 12th, 2026
Read more